search
Back to results

Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus and Their Offspring (MySweetHeart)

Primary Purpose

Gestational Diabetes Mellitus

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
interdisciplinary lifestyle and psychosocial intervention
Sponsored by
University of Lausanne Hospitals
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gestational Diabetes Mellitus focused on measuring gestational diabetes mellitus, randomized controlled trial, lifestyle intervention, cardiovascular, metabolic, mental health, depression, physical activity, dietary intervention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Women and their partners aged 18 yrs or older, with GDM at 24-32 weeks of gestation, and understanding French or English.

Exclusion Criteria:

  • Women on strict bed-rest, with pre-existing diabetes or known severe mental disorder.

Sites / Locations

  • University Hospital Lausanne

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

interdisciplinary lifestyle/psychosocial

treatment as usual

Arm Description

The multidimensional interdisciplinary lifestyle and psychosocial intervention will be offered on top of usual care. It will consist of individual sessions (face-to-face or telephone contact) with different members of the interdisciplinary team (dietician, physiotherapist, clinical psychologist or coach) and two group sessions.

Usual clinical follow-up and treatment is based on the current American Diabetes Association, the Endocrine Society guidelines, and the NICE guidelines.

Outcomes

Primary Outcome Measures

maternal weight measured on calibrated scale
decrease in maternal weight between study inclusion after GDM diagnosis and 1 year postpartum
Self-reported symptoms of depression (mother) measured by Edinburgh Postnatal Depression Scale
decrease in maternal symptoms of depression between study inclusion after GDM diagnosis and 1 year postpartum

Secondary Outcome Measures

Body composition (mother and infant) measured by bioelectrical impedance analysis
Skinfolds (mother and infant) measured by calipers
Total and regional fat mass measured by Dual-Energy X-Ray absorptiometry (mother)
Self-reported food intake (mother) measured by Food Frequency Questionnaire
Self-reported eating behavior (mother) measured by French Intuitive Eating Scale
Self-reported breastfeeding (mother) measured by questionnaire
Self-reported feeding to soothe (mother) measured by Food to Soothe Questionnaire
Self-reported recognition of hunger/satiety cues (mother) measured by Infant Feeding Style Questionnaire
Physical activity (mother) measured by Accelerometer
Aerobic fitness (mother) measured by Chester Step Test
Grip strength (mother) measured by Jamar dynamometer
Self-reported anxiety (mother) measured by Hospital Anxiety and Depression Scale
Self-reported well-being (mother) measured by WHO Well-being Index
Self-reported social support (mother) measured by Medical Outcomes Study Social Support Survey-short form
Weight (infant) measured on calibrated scale
Laboratory variables (mother): Lipid levels
Cardiometabolic laboratory variables (mother), HDL cholesterol, LDL cholesterol, total cholesterol, triglycerides, HbA1C, insulin, glucose, indices of insulin resistance and insulin secretion, gamma-GT, B12 vitamin, ferritine, and miRNA
Fasting laboratory at inclusion and in addition 75 g oral glucose tolerance test at 6-8 weeks postpartum and 1 year postpartum
Cord blood sample at the time of delivery for lipid levels
Cord blood sample at the time of delivery for glucose control
Cord blood sample at the time of delivery for insulin indices
Cord blood sample at the time of delivery for Ferritin and Vitamin B12
Cord blood sample at the time of delivery for miRNA
Laboratory variables (mother): insulin, glucose, indices of insulin resistance and insulin secretion,
Fasting laboratory at inclusion and in addition 75 g oral glucose tolerance test at 6-8 weeks postpartum and 1 year postpartum
Laboratory (mother): gamma-GT, B12 vitamin, ferritine
Laboratory (mother): miRNA

Full Information

First Posted
August 5, 2016
Last Updated
October 31, 2022
Sponsor
University of Lausanne Hospitals
search

1. Study Identification

Unique Protocol Identification Number
NCT02890693
Brief Title
Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus and Their Offspring
Acronym
MySweetHeart
Official Title
Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus (GDM) and Their Offspring: MySweetHeart Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
September 2016 (Actual)
Primary Completion Date
October 25, 2021 (Actual)
Study Completion Date
October 25, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Lausanne Hospitals

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
MySweetHeart Trial is a randomized controlled trial to test the effect of a multidimensional interdisciplinary lifestyle and psychosocial intervention to improve the cardio-metabolic and mental health of women with GDM and their offspring. Primary objective of MySweetHeart Trial: To test the effect of a multidimensional interdisciplinary lifestyle and psychosocial intervention in women with GDM to improve 1) their metabolic health (decrease in maternal weight between study inclusion after GDM diagnosis and at 1 yr postpartum) and 2) their mental health (decrease in maternal symptoms of depression during the same time period). Secondary objective of MySweetHeart Trial: To test the effect of a multidimensional interdisciplinary lifestyle and psychosocial intervention to improve other cardio-metabolic and mental health markers in women with GDM and their offspring. MySweetHeart trial is linked to MySweetHeart Cohort, an observational cohort study that assesses the effect of GDM on offspring cardiovascular health early in life. The principal investigators of the cohort are Nicole Sekarski and Arnaud Chiolero (University Hospital Lausanne, Switzerland). Their primary objective is to assess the effect of GDM on the surrogate markers of cardiovascular disease (CVD) at birth (left ventricular mass index and subclinical atherosclerosis) and the secondary objective is to assess the effect of GDM on the cardiovascular structure and function during the fetal period and neonatal adverse cardiovascular risk factors.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes Mellitus
Keywords
gestational diabetes mellitus, randomized controlled trial, lifestyle intervention, cardiovascular, metabolic, mental health, depression, physical activity, dietary intervention

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
211 (Actual)

8. Arms, Groups, and Interventions

Arm Title
interdisciplinary lifestyle/psychosocial
Arm Type
Experimental
Arm Description
The multidimensional interdisciplinary lifestyle and psychosocial intervention will be offered on top of usual care. It will consist of individual sessions (face-to-face or telephone contact) with different members of the interdisciplinary team (dietician, physiotherapist, clinical psychologist or coach) and two group sessions.
Arm Title
treatment as usual
Arm Type
No Intervention
Arm Description
Usual clinical follow-up and treatment is based on the current American Diabetes Association, the Endocrine Society guidelines, and the NICE guidelines.
Intervention Type
Behavioral
Intervention Name(s)
interdisciplinary lifestyle and psychosocial intervention
Other Intervention Name(s)
lifestyle intervention, physical activity, dietary intervention, psychosocial intervention
Intervention Description
The multidimensional interdisciplinary lifestyle and psychosocial intervention will be offered on top of usual care. It will consist of individual sessions (face-to-face or telephone contact) with different members of the interdisciplinary team (dietician, physiotherapist, clinical psychologist or coach) and two group sessions. It will take place during pregnancy and during the first year postpartum.
Primary Outcome Measure Information:
Title
maternal weight measured on calibrated scale
Description
decrease in maternal weight between study inclusion after GDM diagnosis and 1 year postpartum
Time Frame
study inclusion after GDM diagnosis and 1 year postpartum
Title
Self-reported symptoms of depression (mother) measured by Edinburgh Postnatal Depression Scale
Description
decrease in maternal symptoms of depression between study inclusion after GDM diagnosis and 1 year postpartum
Time Frame
study inclusion after GDM diagnosis and 1 year postpartum
Secondary Outcome Measure Information:
Title
Body composition (mother and infant) measured by bioelectrical impedance analysis
Time Frame
study inclusion after GDM diagnosis (mother), 6-8 weeks postpartum (mother), 1 year postpartum (infant)
Title
Skinfolds (mother and infant) measured by calipers
Time Frame
study inclusion after GDM diagnosis (mother), 6-8 weeks postpartum (mother), 1 year postpartum (infant)
Title
Total and regional fat mass measured by Dual-Energy X-Ray absorptiometry (mother)
Time Frame
1 year postpartum
Title
Self-reported food intake (mother) measured by Food Frequency Questionnaire
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported eating behavior (mother) measured by French Intuitive Eating Scale
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported breastfeeding (mother) measured by questionnaire
Time Frame
6-8- weeks postpartum, 1 year postpartum
Title
Self-reported feeding to soothe (mother) measured by Food to Soothe Questionnaire
Time Frame
1 year postpartum
Title
Self-reported recognition of hunger/satiety cues (mother) measured by Infant Feeding Style Questionnaire
Time Frame
1 year postpartum
Title
Physical activity (mother) measured by Accelerometer
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Aerobic fitness (mother) measured by Chester Step Test
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Grip strength (mother) measured by Jamar dynamometer
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported anxiety (mother) measured by Hospital Anxiety and Depression Scale
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported well-being (mother) measured by WHO Well-being Index
Time Frame
study inclusion after GDM diagnosis, 33-38 weeks GA, 6-8 weeks postpartum,1 year postpartum
Title
Self-reported social support (mother) measured by Medical Outcomes Study Social Support Survey-short form
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Weight (infant) measured on calibrated scale
Time Frame
6-8 weeks postpartum, 1 year postpartum
Title
Laboratory variables (mother): Lipid levels
Time Frame
study inclusion after GDM diagnosis, 6-8 weeks postpartum, 1 year postpartum
Title
Cardiometabolic laboratory variables (mother), HDL cholesterol, LDL cholesterol, total cholesterol, triglycerides, HbA1C, insulin, glucose, indices of insulin resistance and insulin secretion, gamma-GT, B12 vitamin, ferritine, and miRNA
Description
Fasting laboratory at inclusion and in addition 75 g oral glucose tolerance test at 6-8 weeks postpartum and 1 year postpartum
Time Frame
study inclusion after GDM diagnosis, 6-8 weeks postpartum, 1 year postpartum
Title
Cord blood sample at the time of delivery for lipid levels
Time Frame
At delivery
Title
Cord blood sample at the time of delivery for glucose control
Time Frame
At delivery
Title
Cord blood sample at the time of delivery for insulin indices
Time Frame
At delivery
Title
Cord blood sample at the time of delivery for Ferritin and Vitamin B12
Time Frame
At delivery
Title
Cord blood sample at the time of delivery for miRNA
Time Frame
At delivery
Title
Laboratory variables (mother): insulin, glucose, indices of insulin resistance and insulin secretion,
Description
Fasting laboratory at inclusion and in addition 75 g oral glucose tolerance test at 6-8 weeks postpartum and 1 year postpartum
Time Frame
study inclusion after GDM diagnosis, 6-8 weeks postpartum, 1 year postpartum
Title
Laboratory (mother): gamma-GT, B12 vitamin, ferritine
Time Frame
study inclusion after GDM diagnosis, 6-8 weeks postpartum, 1 year postpartum
Title
Laboratory (mother): miRNA
Time Frame
study inclusion after GDM diagnosis, 6-8 weeks postpartum, 1 year postpartum
Other Pre-specified Outcome Measures:
Title
Self-reported sleep quality and quantity (mother) measured by Pittsburgh Sleep Quality Index
Time Frame
study inclusion after GDM diagnosis
Title
Self-reported parenting stress (mother) measured by Parenting Stress Scale-short form
Time Frame
1 year postpartum
Title
Sleep quality and quantity of the infant measured by maternal self-report (Brief Infant Sleep Questionnaire)
Time Frame
1 year postpartum
Title
Weight of partner measured on calibrated scale
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported eating behavior (partner) measured by French Intuitive Eating Scale
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported well-being (partner) measured by WHO Well-being Index
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported symptoms of depression (partner) measured by Edinburgh Postnatal Depression Scale
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported anxiety (partner) measured by Hospital Anxiety and Depression Scale
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported social support (partner) measured by Medical Outcomes Study Social Support Survey-short form
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum
Title
Self-reported parenting stress (partner) measured by Parenting Stress Scale-short form
Time Frame
1 year postpartum
Title
Self-reported life events (mother, partner) measured by Life Events Questionnaire
Time Frame
study inclusion after GDM diagnosis, 1 year postpartum

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Women and their partners aged 18 yrs or older, with GDM at 24-32 weeks of gestation, and understanding French or English. Exclusion Criteria: Women on strict bed-rest, with pre-existing diabetes or known severe mental disorder.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jardena Puder, MD
Organizational Affiliation
University of Lausanne Hospitals
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Antje Horsch, DClinPsych
Organizational Affiliation
University of Lausanne Hospitals
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Lausanne
City
Lausanne
State/Province
Vaud
ZIP/Postal Code
1011
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
29487077
Citation
Horsch A, Gilbert L, Lanzi S, Gross J, Kayser B, Vial Y, Simeoni U, Hans D, Berney A, Scholz U, Barakat R, Puder JJ; MySweetHeart Research Group. Improving cardiometabolic and mental health in women with gestational diabetes mellitus and their offspring: study protocol for MySweetHeart Trial, a randomised controlled trial. BMJ Open. 2018 Feb 27;8(2):e020462. doi: 10.1136/bmjopen-2017-020462.
Results Reference
derived
PubMed Identifier
29138200
Citation
Di Bernardo S, Mivelaz Y, Epure AM, Vial Y, Simeoni U, Bovet P, Estoppey Younes S, Chiolero A, Sekarski N; MySweetHeart Research Group. Assessing the consequences of gestational diabetes mellitus on offspring's cardiovascular health: MySweetHeart Cohort study protocol, Switzerland. BMJ Open. 2017 Nov 14;7(11):e016972. doi: 10.1136/bmjopen-2017-016972.
Results Reference
derived

Learn more about this trial

Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus and Their Offspring

We'll reach out to this number within 24 hrs